Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Laura Esteban-Lucía"'
Autor:
Óscar González-Lorenzo, Ana Rodriguez, Ana María Pello-Lázaro, Borja Ibanez, Álvaro Aceña, José Tuñón, Andrea María Kallmeyer Mayor, Maria De Los Angeles Zambrano Chacon, Ricardo Fernández Roblas, Juan Antonio Franco-Peláez, Felipe Villar Álvarez, Laura Esteban-Lucía, Camila Sofia García-Talavera, Luis Nieto Roca
Publikováno v:
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 1 (2021)
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 1 (2021)
Background Several studies suggest that statins, besides reducing cardiovascular disease, have anti-inflammatory properties which might provide a benefit in downregulating the immune response after a respiratory viral infection (RVI) and, hence, decr
Autor:
O Gonzalez Lorenzo, Julia Anna Palfy, Marta López-Castillo, A. Kallmeyer Mayor, Laura Esteban-Lucía, P Avila Barahona, A Romero-Daza, Juan Martínez-Milla, J Tunon, Roberto Martín-Reyes, A. Pinero Lozano, Juan Antonio Franco-Peláez
Publikováno v:
European Heart Journal. 42
Background Stress cardiomyopathy (SCM) is a transient ventricular dysfunction frequently precipitated by acute emotional or physical stress. According to ventricular contractile pattern there are four SCM variants, being apical (80%) and midventricul
Autor:
R Fernandez-Roblas, Óscar González-Lorenzo, A M Venegas Rodriguez, M A Zambrano Chacon, F Villar-Alvarez, Laura Esteban-Lucía, J Tunon, L Maure-Blesa, A Acena Navarro, Juan Antonio Franco-Peláez, M Gonzalez-Rodriguez, A Devesa-Arbiol, Ana María Pello-Lázaro, P Avila-Barahona, A M Kallmeyer-Mayor
Publikováno v:
European Heart Journal
Background High incidence of cardiovascular events has been described among patients with COVID-19 and since the beginning of the pandemic concerns have been expressed with medical treatments for cardiovascular disease, as they could contribute to th
Autor:
R Fernandez-Roblas, L Maure-Blesa, M Gonzalez-Rodriguez, J A Franco Pelaez, Óscar González-Lorenzo, J Tunon, Ana María Pello-Lázaro, A Devesa-Arbiol, A M Venegas Rodriguez, M A Zambrano Chacon, Borja Ibanez, A Acena Navarro, P Avila-Barahona, Laura Esteban-Lucía, F Villar-Alvarez
Publikováno v:
European Heart Journal. 42
Background On January 2020, the first patient with coronavirus 2 (SARS-CoV-2) was detected in Spain. Since then, 3 280 000 cases have been confirmed and 75.305 people have died. We aimed to clarify the epidemiological and clinical characteristics rel
Autor:
R Fernandez-Roblas, F Villar-Alvarez, Óscar González-Lorenzo, Laura Esteban-Lucía, M Gonzalez-Rodriguez, P Avila-Barahona, A M Venegas Rodriguez, M A Zambrano Chacon, A Acena Navarro, A M Kallmeyer-Mayor, J Tunon, A Devesa-Arbiol, Juan Antonio Franco-Peláez, L Maure-Blesa, Ana María Pello-Lázaro
Publikováno v:
European Heart Journal. 42
Background Questions emerged about safety renin-angiotensin system (RAS) inhibitors (angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs)) in patients diagnosed with severe acute respiratory syndrome coronavirus-2 (
Autor:
Laura Esteban-Lucía, Andrea María Kallmeyer Mayor, Soraya De la Fuente Batista, Marcelino Cortés García
Publikováno v:
Stroke. 52
Autor:
Maria De Los Angeles Zambrano Chacon, Ana María Venegas Rosríguez, Ainhoa Izquierdo Pérez, Ana María Pello Lázaro, Camila Sofía García-Talavera, Álvaro Aceña Navarro, Laura Esteban-Lucía, Felipe Villar Álvarez, Luis Nieto Roca
Publikováno v:
Clinical problems.
Autor:
Maria De Los Angeles Zambrano Chacon, Álvaro Aceña Navaroo, Ana María Pello Lázaro, Laura Esteban-Lucía, Felipe Villar Álvarez, Ana Rodriguez, Ainhoa Izquierdo Pérez, Camila Sofía García Talavera, Luis Nieto Roca
Publikováno v:
Respiratory infections.
Autor:
Laura Esteban-Lucía, Felipe Villar Álvarez, Luis Nieto Roca, Camila Sofía García Talavera, Álvaro Aceña Navarro, Maria De Los Angeles Zambrano Chacon, Ricardo Fernández Roblas, Ana María Pello Lázaro, Ana Rodriguez
Publikováno v:
Monitoring airway disease.
Autor:
Juan Antonio Franco-Peláez, Laura Esteban-Lucia, María de los Ángeles Zambrano Chacón, Ana María Pello-Lázaro, Ana María Venegas Rodriguez, Luis Nieto Roca, Camila Sofia García-Talavera, Andrea Kallmeyer Mayor, Felipe Villar Alvarez, Ricardo Fernandez Roblas, Oscar Gonzalez-Lorenzo, José Tuñón, Borja Ibañez, Alvaro Aceña
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
Background Several studies suggest that statins, besides reducing cardiovascular disease, have anti-inflammatory properties which might provide a benefit in downregulating the immune response after a respiratory viral infection (RVI) and, hence, decr
Externí odkaz:
https://doaj.org/article/388605c150ad448598f1bc7fd64f491d